Related references
Note: Only part of the references are listed.Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population
C-C Chang et al.
PHARMACOGENOMICS JOURNAL (2017)
Cutaneous Manifestation of Drug Allergy and Hypersensitivity
Anna Zalewska-Janowska et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13:01 allele in the Thai population
Therdpong Tempark et al.
PHARMACOGENETICS AND GENOMICS (2017)
Genomics of Adverse Drug Reactions
Ana Alfirevic et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
Napatrupron Koomdee et al.
FRONTIERS IN PHARMACOLOGY (2017)
The HLA-A*31:01 allele: influence on carbamazepine treatment
Vincent Lai Ming Yip et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2017)
HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese
F. Yang et al.
PHARMACOGENOMICS JOURNAL (2016)
Impact of the HLA-B*58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions
Chau Yee Ng et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population
Wichittra Tassaneeyakul et al.
PHARMACOGENETICS AND GENOMICS (2016)
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update
Roni P. Dodiuk-Gad et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2015)
T Cell-Mediated Hypersensitivity Reactions to Drugs
Rebecca Pavlos et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy
Catrin O. Plumpton et al.
EPILEPSIA (2015)
The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population
Jangsup Moon et al.
EPILEPSIA (2015)
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects
Valentina Franco et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Acute generalized exanthematous pustulosis (AGEP): A review and update
Jesse Szatkowski et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN): Could Retinoids Play a Causative Role?
Sridhar Karre
MEDICAL SCIENCE MONITOR (2015)
Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back
Rik Schrijvers et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2015)
Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin
Wen-Hung Chung et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine
Hye Jung Park et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia
Wen Yi Ding et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis
Tao Zeng et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Abacavir-Reactive Memory T Cells Are Present in Drug Naive Individuals
Andrew Lucas et al.
PLOS ONE (2015)
Five-Year Retrospective Review of Acute Generalized Exanthematous Pustulosis
Chitprapassorn Thienvibul et al.
DERMATOLOGY RESEARCH AND PRACTICE (2015)
Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions
Munir Pirmohamed
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 15 (2014)
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing
K. E. Caudle et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
Ursula Amstutz et al.
EPILEPSIA (2014)
Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
Wen-Hung Chung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations
Daniel F. Carr et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
E. Genin et al.
PHARMACOGENOMICS JOURNAL (2014)
Single centre 20 year survey of antiepileptic drug-induced hypersensitivity reactions
Barbara Błaszczyk et al.
Pharmacological Reports (2014)
Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine- related Stevens-Johnson syndrome with severe mucosal involvement
Mayumi Ueta et al.
SCIENTIFIC REPORTS (2014)
Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications
Mayumi Ueta et al.
SCIENTIFIC REPORTS (2014)
HLA Associations and Clinical Implications in T-Cell Mediated Drug Hypersensitivity Reactions: An Updated Review
Chi-Yuan Cheng et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Anticonvulsant hypersensitivity syndrome associated with carbamazepine administration: Case series
Maulin Mehta et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2014)
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
S. H. Kardaun et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response
J. Yun et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2013)
Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population
Daniel F. Carr et al.
CLINICAL INFECTIOUS DISEASES (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
M. S. Hershfield et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
S. G. Leckband et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in Southeast Asia
Haur Yueh Lee et al.
DERMATOLOGICA SINICA (2013)
HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
Ying-Kit Cheung et al.
EPILEPSIA (2013)
Clinical Features and Prognostic Factors in Severe Cutaneous Drug Reactions
Min-Suk Yang et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Association between HLA-B*1301 and Dapsone-Induced Hypersensitivity Reactions among Leprosy Patients in China
Hongsheng Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome
Fu-Ren Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children
Wiparat Manuyakorn et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2013)
Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects
Nahoko Kaniwa et al.
PHARMACOGENOMICS (2013)
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
M. Tohkin et al.
PHARMACOGENOMICS JOURNAL (2013)
Relationship Between the HLA-B*1502 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis A Systematic Review and Meta-analysis
Wimonchat Tangamornsuksan et al.
JAMA DERMATOLOGY (2013)
Hypersensitivity Reactions to Dapsone: A Systematic Review
Maria Lorenz et al.
ACTA DERMATO-VENEREOLOGICA (2012)
HLA-Dependent Hypersensitivity Reaction to Nevirapine in Chinese Han HIV-Infected Patients
Shicheng Gao et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA
J. Yun et al.
ALLERGY (2012)
HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
V. L. Yip et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
M. A. Martin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Avidity determines T-cell reactivity in abacavir hypersensitivity
Jacqueline Adam et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?
M. H. Lee et al.
INTERNAL MEDICINE JOURNAL (2012)
Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis
Wen-Hung Chung et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
Patricia T. Illing et al.
NATURE (2012)
Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
Di Dong et al.
NEUROLOGY (2012)
Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions
Mark McCormack et al.
PHARMACOGENOMICS (2012)
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
David A. Ostrov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Spontaneous Reporting of Adverse Drug Reactions through Electronic Submission from Regional Society Healthcare Professionals in Korea
Jae-Hyun Lee et al.
YONSEI MEDICAL JOURNAL (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
Kongkiat Kulkantrakorn et al.
PAIN PRACTICE (2012)
Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
Ratchadaporn Somkrua et al.
BMC MEDICAL GENETICS (2011)
Hypersensitivity reactions to HIV therapy
Mas Chaponda et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
Sae-Hoon Kim et al.
EPILEPSY RESEARCH (2011)
Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
M. Isabel Lucena et al.
GASTROENTEROLOGY (2011)
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
Takeshi Ozeki et al.
HUMAN MOLECULAR GENETICS (2011)
Stevens-Johnson syndrome induced by acetazolamide
Young Her et al.
JOURNAL OF DERMATOLOGY (2011)
Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
Pei Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans
Hye-Ryun Kang et al.
PHARMACOGENETICS AND GENOMICS (2011)
Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland
Qian Wang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Drug Induced Hypersensitivity and the HLA Complex
Ana Alfirevic et al.
PHARMACEUTICALS (2011)
Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
Wichittra Tassaneeyakul et al.
EPILEPSIA (2010)
HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
Hiroko Ikeda et al.
EPILEPSIA (2010)
Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
X. T. Wu et al.
EPILEPSY & BEHAVIOR (2010)
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
Jonathan B. Singer et al.
NATURE GENETICS (2010)
Pharmacogenetics of drug hypersensitivity
Elizabeth J. Philips et al.
PHARMACOGENOMICS (2010)
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
Shuen-Iu Hung et al.
PHARMACOGENOMICS (2010)
HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis
Sae-Hoon Kim et al.
PHARMACOGENOMICS (2010)
Should HLA-B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?
Wan Beom Park et al.
CLINICAL INFECTIOUS DISEASES (2009)
Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians
Timir Y. Mehta et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Emma C. Davies et al.
PLOS ONE (2009)
High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients
Gbenga R. Kazeem et al.
PHARMACOGENETICS AND GENOMICS (2009)
HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients
Soranun Chantarangsu et al.
PHARMACOGENETICS AND GENOMICS (2009)
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population
Wichittra Tassaneeyakul et al.
PHARMACOGENETICS AND GENOMICS (2009)
High sensitivity of human leukocyte antigen-B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
Michael Saag et al.
CLINICAL INFECTIOUS DISEASES (2008)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
Cross-reactivity pattern of rash from current aromatic antiepileptic drugs
Sije Alvestad et al.
EPILEPSY RESEARCH (2008)
Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients
Mariko Kashiwagi et al.
JOURNAL OF DERMATOLOGY (2008)
Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
Maja Mockenhaupt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
Wen-Hung Chung et al.
NATURE MEDICINE (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
Christine Lonjou et al.
PHARMACOGENETICS AND GENOMICS (2008)
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
Nahoko Kaniwa et al.
PHARMACOGENOMICS (2008)
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
P. Brent Ferrell et al.
PHARMACOGENOMICS (2008)
Risk factors for acute generalized exanthematous pustulosis (AGEP) - results of a multinational case-control study (EuroSCAR)
A. Sidoroff et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A complex interaction between drug allergy and viral infection
Tetsuo Shiohara et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2007)
Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome
Mayumi Ueta et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations
T. Shiohara et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese
Celeste B. L. Man et al.
EPILEPSIA (2007)
Toxic epidermal necrolysis
Frederick A. Pereira et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?
S. H. Kardaun et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome
M. Seishima et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV Cohort study
A. Rauch et al.
CLINICAL INFECTIOUS DISEASES (2006)
A marker for Stevens-Johnson syndrome ...: ethnicity matters
C. Lonjou et al.
PHARMACOGENOMICS JOURNAL (2006)
Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non-linear Mixed Effects Model approach
E. Yukawa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Shuen-Lu Hung et al.
PHARMACOGENETICS AND GENOMICS (2006)
HLA-B locus in Caucasian patients with carbamazepine hypersensitivity
Ana Alfirevic et al.
PHARMACOGENOMICS (2006)
Epidemiology of hypersensitivity drug reactions
ER Gomes et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Clinical heterogeneity of drug hypersensitivity
JC Roujeau
TOXICOLOGY (2005)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin
S Roychowdhury et al.
AAPS JOURNAL (2005)
Phenobarbital for the treatment of epilepsy in the 21st century: A critical review
P Kwan et al.
EPILEPSIA (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity
DA Hughes et al.
PHARMACOGENETICS (2004)
Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction
Y Aihara et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Immunopharmacology of hypersensitivity reactions to drugs
DJ Naisbitt et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2003)
Risk factor analysis of hypersensitivity reactions to abacavir
W Symonds et al.
CLINICAL THERAPEUTICS (2002)
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis
A Nassif et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
S Hetherington et al.
CLINICAL THERAPEUTICS (2001)
Acute generalized exanthematous pustulosis (AGEP) - A clinical reaction pattern
A Sidoroff et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2001)
Gell and Coombs's classification: is it still valid?
J Descotes et al.
TOXICOLOGY (2001)
Share Paper
